Cargando…
Combination of Obestatin and Bone Marrow Mesenchymal Stem Cells Prevents Aggravation of Endocrine Pancreatic Damage in Type II Diabetic Rats
One of the new promising therapies in treatment of diabetes mellitus is mesenchymal stem cells (MSCs) which have an interesting therapeutic potentiality based on their paracrine effect and transdifferentiation potentiality. Also obestatin improves the generation of functional β cells/islet-like cell...
Autores principales: | Hussien, Noha I, Ebrahim, Nesrine, Mohammed, Ola M, Sabry, Dina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Stem Cell Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741194/ https://www.ncbi.nlm.nih.gov/pubmed/29186652 http://dx.doi.org/10.15283/ijsc17035 |
Ejemplares similares
-
Bone marrow-derived mesenchymal stem cells combined with gonadotropin therapy restore postnatal oogenesis of chemo-ablated ovaries in rats via enhancing very small embryonic-like stem cells
por: Ebrahim, Nesrine, et al.
Publicado: (2021) -
Does vitamin C have the ability to augment the therapeutic effect of bone marrow-derived mesenchymal stem cells on spinal cord injury?
por: Salem, Nesrine, et al.
Publicado: (2017) -
Mesenchymal Stem Cell-Derived Exosomes Ameliorated Diabetic Nephropathy by Autophagy Induction through the mTOR Signaling Pathway
por: Ebrahim, Nesrine, et al.
Publicado: (2018) -
Serum ghrelin, but not obestatin, is a potential predictor of acute pancreatitis severity
por: Wang, Huilin, et al.
Publicado: (2017) -
The NMR Structure of Human Obestatin in Membrane-Like Environments: Insights into the Structure-Bioactivity Relationship of Obestatin
por: Alén, Begoña O., et al.
Publicado: (2012)